The New Zealand sharemarket posted its fourth decline in five trading days, with Auckland International Airport falling nearly 2.5%, while the Australian benchmark index reached an all-time high.

Wall Street returned to some normality, the New Zealand sharemarket had a rise after a rocky session, and Australian inflation was lower, paving the way for an interest rate cut there.

The New Zealand sharemarket, dictated by the volatile Fisher and Paykel Healthcare stock, posted another small decline and avoided the upheaval in the technology sector on Wall Street.

A recovering Synlait Milk continued to climb on a quiet day on the New Zealand sharemarket when the top half of the North Island was on holiday for Auckland’s Anniversary.

Synlait Milk rose nearly 20% after indicating a return to profitability as the New Zealand sharemarket drifted to a small decline on light trading.

Fisher and Paykel Healthcare hit a record high and led the New Zealand sharemarket to a small gain, while Wall St kept striding ahead following President Donald Trump’s inauguration.

The New Zealand sharemarket posted a small loss as inflation remained under control, prompting renewed calls for a big interest rate cut next month.

President Donald Trump’s renewed tariff threats on his inauguration day rattled Fisher and Paykel Healthcare while the New Zealand sharemarket lacked any real direction.

A takeover offer for Millennium and Copthorne Hotels NZ brightened an otherwise quiet day on the New Zealand sharemarket that started the week with a 0.3% decline.

The New Zealand sharemarket ended a strong week with a gain of more than 1.8%, erasing the year’s earlier losses, and powered by heavyweight Fisher and Paykel Healthcare as it neared a record high.

The New Zealand sharemarket posted its third successive rise of nearly 0.5% following a strong rally in the United States on softer-than-expected inflation data and improved earnings from leading banks.

Auckland International Airport and the tourism sector are benefiting from increased visitor numbers – the best in five years – as the New Zealand sharemarket posted a gain of nearly 0.5%.

The New Zealand sharemarket bounced back from three successive down days as the latest data showed the economy is slowly recovering, prompting renewed hope of a 0.5% cut in the official cash rate next month.

Cancer diagnostic company Pacific Edge slumped 55% after failing to get the backing for continued United States Medicare payments for its Cxbladder tests, and the New Zealand sharemarket joined global moves with a fall.

Leading retailer Briscoe Group downgraded its annual earnings by 10% on “continued subdued trading” as the New Zealand sharemarket ended a quiet week with a small fall.

The New Zealand stock exchange remains in “limbo” as international markets brace for the incoming second term of US President Trump.